Mitochondrial stress response in drug-induced liver injury

Mol Biol Rep. 2021 Oct;48(10):6949-6958. doi: 10.1007/s11033-021-06674-6. Epub 2021 Aug 25.

Abstract

Drug-induced liver injury (DILI) caused by the ingestion of medications, herbs, chemicals or dietary supplements, is a clinically widespread health problem. The underlying mechanism of DILI is the formation of reactive metabolites, which trigger mitochondrial oxidative stress and the opening of mitochondrial permeability transition (MPT) pores through direct toxicity or immune response, leading to cell inflammation, apoptosis, and necrosis. Traditionally, mitochondria play an indispensable role in maintaining the physiological and biochemical functions of cells by producing ATP and mediating intracellular signal transduction; drugs can typically stimulate the mitochondria and, in the case of sustained stress, can eventually cause impairment of mitochondrial function and metabolic activity. Meanwhile, the mitochondrial stress response, as an adaptive protective mechanism, occurs when mitochondrial homeostasis is threatened. In this review, we summarize the relevant frontier researches of the protective effects of mitochondrial stress response in DILI as well as the potential related mechanisms, thus providing some thoughts for the clinical treatment of DILI.

Keywords: Adaptive protective mechanism; Drug-induced liver injury; Mitochondrial homeostasis; Mitochondrial stress response.

Publication types

  • Review

MeSH terms

  • Animals
  • Chemical and Drug Induced Liver Injury / pathology*
  • Humans
  • Mitochondria / pathology*
  • Models, Biological
  • Pharmaceutical Preparations
  • Stress, Physiological*

Substances

  • Pharmaceutical Preparations